BHCM
EXAS

Brevan Howard Capital Management’s Exact Sciences EXAS Stock Holding History

Brevan Howard Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-35,637
Closed -$3.62M – 2243
2025
Q4 		$3.62M Buy
+35,637
New +$2.86M 0.04% 314
2025
Q3 		– Sell
-31,422
Closed -$1.67M – 2030
2025
Q2 		$1.67M Buy
+31,422
New +$1.6M 0.01% 825
2024
Q4 		– Sell
-22,895
Closed -$1.56M – 1163
2024
Q3 		$1.56M Buy
+22,895
New +$1.29M 0.01% 322

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Brevan Howard Capital Management's EXAS Position: Q1 2026 in Review

Brevan Howard Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 35,637 shares — an estimated $3.62M sold.

Brevan Howard Capital Management first reported a position in EXAS in Q3 2024 and held it in 3 quarters. The position peaked at $3.62M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Brevan Howard Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 35,637 Exact Sciences shares in Q1 2026, an estimated $3.62M.
  • Brevan Howard Capital Management first reported a position in Exact Sciences in Q3 2024 and held it in 3 quarters.
  • Brevan Howard Capital Management's Exact Sciences position peaked at $3.62M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.